Vironcology - not yet, but soon? - Engineering the regulatory pathways of a replicating oncolytic adenovirus enhances selective destruction of tumor cells.

被引：5

作者：

Vile, RG ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA

来源：

NATURE BIOTECHNOLOGY | 2001年 / 19卷 / 11期

关键词：

D O I：

10.1038/nbt1101-1020

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Engineering the regulatory pathways of a replicating oncolytic adenovirus enhances selective destruction of tumor cells.

引用

页码：1020 / 1022

页数：3

共 10 条

[1] Replicative adenoviruses for cancer therapy [J].

Alemany, R ;

Balagué, C ;

Curiel, DT .

NATURE BIOTECHNOLOGY, 2000, 18 (07) :723-727

[2] An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [J].

Bischoff, JR ;

Kim, DH ;

Williams, A ;

Heise, C ;

Horn, S ;

Muna, M ;

Ng, L ;

Nye, JA ;

SampsonJohannes, A ;

Fattaey, A ;

McCormick, F .

SCIENCE, 1996, 274 (5286) :373-376

[3] Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice [J].

Grote, D ;

Russell, SJ ;

Cornu, TI ;

Cattaneo, R ;

Vile, R ;

Poland, GA ;

Fielding, AK .

BLOOD, 2001, 97 (12) :3746-3754

[4] A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer [J].

Khuri, FR ;

Nemunaitis, J ;

Ganly, I ;

Arseneau, J ;

Tannock, IF ;

Romel, L ;

Gore, M ;

Ironside, J ;

MacDougall, RH ;

Heise, C ;

Randlev, B ;

Gillenwater, AM ;

Bruso, P ;

Kaye, SB ;

Hong, WK ;

Kirn, DH .

NATURE MEDICINE, 2000, 6 (08) :879-885

[5]

KIM D, 2001, NAT MED, V7, P781

[6] A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors [J].

Logg, CR ;

Tai, CK ;

Logg, A ;

Anderson, WF ;

Kasahara, N .

HUMAN GENE THERAPY, 2001, 12 (08) :921-932

[7] Systemic therapy of myeloma xenografts by an attenuated measles virus [J].

Peng, KW ;

Ahmann, GJ ;

Pham, L ;

Greipp, PR ;

Cattaneo, R ;

Russell, SJ .

BLOOD, 2001, 98 (07) :2002-2007

[8] Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy [J].

Ramachandra, M ;

Rahman, A ;

Zou, AH ;

Vaillancourt, M ;

Howe, JA ;

Antelman, D ;

Sugarman, B ;

Demers, GW ;

Engler, H ;

Johnson, D ;

Shabram, P .

NATURE BIOTECHNOLOGY, 2001, 19 (11) :1035-1041

[9] Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells [J].

Rothmann, T ;

Hengstermann, A ;

Whitaker, NJ ;

Scheffner, M ;

zur Hausen, H .

JOURNAL OF VIROLOGY, 1998, 72 (12) :9470-9478

[10] Cancer gene therapy: hard lessons and new courses [J].

Vile, RG ;

Russell, SJ ;

Lemoine, NR .

GENE THERAPY, 2000, 7 (01) :2-8

← 1 →